Related references
Note: Only part of the references are listed.Activation of the ERK and AKT signalling pathway predicts poor prognosis in hepatocellular carcinoma and ERK activation in cancer tissue is associated with hepatitis C virus infection
Klaus Juergen Schmitz et al.
JOURNAL OF HEPATOLOGY (2008)
The receptor tyrosine kinase EphB4 is overexpressed in ovarian cancer, provides survival signals and predicts poor outcome
S. R. Kumar et al.
BRITISH JOURNAL OF CANCER (2007)
Rac1 mediates intestinal epithelial cell apoptosis via JNK
Shi Jin et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2006)
Ephrin-B3 ligand promotes glioma invasion through activation of Rac1
Mitsutoshi Nakada et al.
CANCER RESEARCH (2006)
The EphB4 receptor suppresses breast cancer cell tumorigenicity through an Abl-Crk pathway
Nicole K. Noren et al.
NATURE CELL BIOLOGY (2006)
The global health burden of infection -associated cancers in the year 2002
Donald Maxwell Parkin
INTERNATIONAL JOURNAL OF CANCER (2006)
EphB4 receptor tyrosine kinase is expressed in bladder cancer and provides signals for cell survival
G Xia et al.
ONCOGENE (2006)
Dysregulation of growth factor signaling in human hepatocellular carcinoma
K. Breuhahn et al.
ONCOGENE (2006)
Ephrin-A1 expression contributes to the malignant characteristics of α- fetoprotein producing hepatocellular carcinoma
H Iida et al.
GUT (2005)
Tumor necrosis factor: How to make a killer molecule tumor-specific?
R Lucas et al.
CURRENT CANCER DRUG TARGETS (2005)
Akt phosphorylation is a risk factor for early disease recurrence and poor prognosis in hepatocellular carcinoma
K Nakanishi et al.
CANCER (2005)
EphA2 receptor tyrosine kinase regulates endothelial cell migration and vascular assembly through phosphoinositide 3-kinase-mediated Rac1 GTPase activation
DM Brantley-Sieders et al.
JOURNAL OF CELL SCIENCE (2004)
Interplay between EphB4 on tumor cells and vascular ephrin-B2 regulates tumor growth
NK Noren et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Differential gene expression of Eph receptors and ephrins in benign human tissues and cancers
C Hafner et al.
CLINICAL CHEMISTRY (2004)
EphA2 expression is associated with aggressive features in ovarian carcinoma
PH Thaker et al.
CLINICAL CANCER RESEARCH (2004)
Invasiveness of breast carcinoma cells and transcript profile: Eph receptors and ephrin ligands as molecular markers of potential diagnostic and prognostic application
BP Fox et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
The continuing increase in the incidence of hepatocellular carcinoma in the United States: An update
H El-Serag et al.
ANNALS OF INTERNAL MEDICINE (2003)
Eph and ephrin signaling in mammary gland morphogenesis and cancer
AC Andres et al.
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA (2003)
Signalling pathways of the TNF superfamily: A double-edged sword
BB Aggarwal
NATURE REVIEWS IMMUNOLOGY (2003)
Expression of ephrin-B1 in hepatocellular carcinoma: possible involvement in neovascularization
Y Sawai et al.
JOURNAL OF HEPATOLOGY (2003)
Activation of the EphA2 tyrosine kinase stimulates the MAP/ERK kinase signaling cascade
RL Pratt et al.
ONCOGENE (2002)
Role of Rel/NF-κB transcription factors in apoptosis of human hepatocellular carcinoma cells
PJ Chiao et al.
CANCER (2002)
Actin turnover is required to prevent axon retraction driven by endogenous actomyosin contractility
G Gallo et al.
JOURNAL OF CELL BIOLOGY (2002)
Occurrence of portal vein tumor thrombus in hepatocellular carcinoma affects prognosis and survival. A retrospective clinical study of 150 cases
G Giannelli et al.
HEPATOLOGY RESEARCH (2002)
Inhibition of protein kinase B/Akt: implications for cancer therapy
MM Hill et al.
PHARMACOLOGY & THERAPEUTICS (2002)
The ephrin-A1 ligand and its receptor, EphA2, are expressed during tumor neovascularization
K Ogawa et al.
ONCOGENE (2000)
Regulated cleavage of a contact-mediated axon repellent
M Hattori et al.
SCIENCE (2000)
Share Paper
